Background: Attentional deficits are prominent in schizophrenia, and skill
learning is impaired. Novel antipsychotic treatment has been reported to im
prove certain cognitive skills in schizophrenic patients. but no informatio
n is yet available about the effect of sewer medications on skill learning.
Methods: Clinically stable patients with schizophrenia (n=16) and chronica
lly hospitalized inpatients (n=8) were recruited while receiving convention
al antipsychotic treatment. Subjects were tested at baseline on a visual co
ntinuous performance test (CPT). performed alone and simultaneously with an
auditory CPT. Normal controls (n=8) were also tested at baseline. The inpa
tients and half of the outpatients were switched to treatment with risperid
one. All patients then performed the visual CPT on a daily basis and perfor
med the dual tasks once per week, for 4 weeks. Results: Patients who remain
ed on conventional medications did not improve in their performance despite
the extensive practice on the test. Both chronic and stable patients recei
ving risperidone treatment manifested a statistically significant (P<0.05)
improvement from baseline on both single and dual-task visual CPT. Stable o
utpatients performed significantly better at the end of the protocol than t
he normal controls performance at baseline (P<0.05). Implications: These re
sults suggest that practice-related improvements in the performance of info
rmation processing tests are enhanced by novel antipsychotic medications. A
lthough the specific biological mechanism of this effect is not yet known,
the results may suggest that use of newer medications will enhance skill de
velopment and perhaps facilitate rehabilitation of patients with schizophre
nia. (C) 2000 Elsevier Science B.V. All rights reserved.